WHY ATTEND
With many biologic patents set to lose exclusivity in 2023 a patent cliff is on the way. Generic, biosimilar and innovator biopharma companies are in different positions and will need to react differently to these changing market circumstances. Additionally, the face of biologics is changing with and increasing number of gene therapy and antibody-drug conjugate options adding to and sometimes taking the place of “naked antibodies”. The Global Biologics, Cell and Gene Summit is perfect place to address these changes with leading industry experts from across the IP, Regulatory and Commercial fields.
Highlights include:
- Understanding how the UPC will shape the future patent landscape for biologic products
- Discover the latest global perspective on the situation for biologics/biosimilars in Europe, US, and Asia.
- Understand the latest regulatory framework for biologic products.
- Learn the latest trends within the biologics marketplace with the commercial, regulatory and IP updates on Cell and Gene products.
HOW TO GET INVOLVED
REGISTER YOUR INTEREST FOR 2024
Join us to network with colleagues and gain insights from industry experts on how you can create new innovative commercial and legal strategies, overcome market barriers, and take advantage of the growing opportunities in the biologic marketspace.
PARTNER WITH US
Based on your objectives we can create bespoke packages especially for you.
From presenting your experience on stage to hosting networking drinks. You can partner with us to showcase your brand and make valuable new connections. Opportunities predominently lie in 3 main categories: Thought Leadership, Branding, and Networking.
Discuss your objectives with Duncan Henderson, Senior Commercial Partnerships Manager; [email protected] or register your your interest in sponsorship here:
REGISTER YOUR INTEREST FOR 2024
We had a great time in June 2023 uncovering the latest global standings in the European, US, and Asian for biologics/biosimilars marketplaces with our community of some of the top in-house and private practice legal representatives.
Interested in joining next year? Fill out this quick form to register your interest and be the first to recieve our 2024 agenda when it's ready
From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick the "YES" box.
Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].
User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].
For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.
2023 Global Biologics, Cell and Gene Legal Summit
GLOBAL BIOLOGICS, CELL & GENE LEGAL SUMMIT 2023 COMMUNITY
From our advisory board and speaking faculty to our media and strategic partners, our series wouldn't be possible without the contributions of our esteemed community of in-house legal representatives, trademark/patent private practice lawyers and legal press
2023 PARTNERS
Platinum Partners
Fish & Richardson
Website: https://www.fr.com/
Few firms have protected more innovative and valuable intellectual property than Fish & Richardson. We work with life sciences companies to protect and maximize the value of their IP so that they may achieve their strategic goals through partnership, licensing, financing, acquisition, and enforcement. The Fish team is comprised of accomplished patent attorneys and agents, many of whom boast Ph.D.s and extensive industry experience. Our clients choose to work with Fish attorneys because of their deep technical backgrounds, their expertise on the latest innovations in the industry, and the breadth of their experience working with life sciences companies of every size and in every field.
Pinsent Masons
Website: https://www.pinsentmasons.com/
Pinsent Masons international Life Sciences practice is one of the best in Europe.
Their team, comprising more than 100 sector specialists, many of whom are leading individuals in their field with relevant scientific degrees (some to Ph.D.) and experience, drawn from industry, is dedicated to helping their clients continue to develop cutting-edge strategies that use the law as a business enabler to positively impact their bottom line.
The team acts for businesses globally on complex market shifting transactions; cutting edge R&D collaboration; partnering and licensing deals; the most high profile, business-critical patent and regulatory litigations; and hugely impactful anti-trust investigations and litigations.
Comprising some of the world’s leading life sciences experts, the team works with senior management and in-house legal teams to navigate complex regulatory environments, develop effective risk management strategies, and spot and convert opportunities.
Gold Partners
Clifford Chance
Website: https://www.cliffordchance.com/home.html
Clifford Chance is one of the world’s pre-eminent law firms, with significant depth and range of human and IT resources across five continents. The firm is always striving to exceed the expectations of its clients, which includes banks and other financial institutions, corporates from all the commercial and industrial sectors, governments, regulators, trade bodies and not-for-profit organisations. Providing the highest quality advice and legal insight, Clifford Chance prides itself on its approachable, team-based and tech-savvy way of working.
Event Partners
Gemini Law
Website: http://www.geminilaw.com/
Gemini attorneys are among the most experienced and successful at helping manufacturers of biopharma products navigate IP barriers to access the U.S. market. Gemini has particular expertise in patent strategy and litigation relating to biosimilar, biobetter, generic and 505(b)(2) products, as well as collateral issues concerning the Hatch Waxman and BPCIA regulatory schemes. Gemini is also very experienced in counseling early-stage biotech companies to optimize patent portfolios and mitigate the risk posed by competitors’ IP, as well as IP issues related to licensing and development transactions. Gemini offers “end to end” counseling on IP issues in support of biopharma product development and launch in the U.S., including:
- Litigation risk mitigation and avoidance
- Patent & trade secret design-around strategies
- Patent portfolio optimization
- Biosimilar (BPCIA) litigation & regulatory strategy
- Hatch Waxman litigation & regulatory strategy
- "Biobetter" & "fast follow-on" product litigation & regulatory strategy
- Pharmaceutical device-related litigation & regulatory strategy
- IP & regulatory issues concerning healthcare AI
- CREATES Act requests & litigation
- Section 1782 discovery requests for use in foreign litigation
- Global coordination of litigation strategy concerning biosimilar, generic and biobetter products
- Patent landscaping and freedom-to-operate opinions
- IP-related licensing, development & manufacturing transactions
- Lobbying and legislative initiatives relating to the BPCIA and Hatch Waxman laws
King & Wood Mallesons
Website: https://www.kwm.com/uk/en/home.html
Please visit our website for more information.Associate Media Partner
CTC Legal Media (Patent Lawyer Magazine)
Website: https://ctclegalmedia.com/
CTC Legal Media are globally renowned publishers of The Trademark Lawyer and The Patent Lawyer Magazines, reporting on core IP matters. Each and every edition is full of exclusive special features including guest interviews with in-house counsel, case comment, and the latest developments in the IP Industry, delivered to a combined hardcopy and digital global readership of over 93,000+ IP professionals.
2023 Media Partners
JUVE
Website: https://www.juve-patent.com
JUVE has been reporting on the UPC, the European Patent Office and developments at law firms and in-house departments for twenty years – and in English since 2018.
JUVE Patent provides daily news coverage, in-depth reports and annual rankings on the four most important European patent markets.
Global Legal Group
Website: https://iclg.com/
ICLG.com is a global resource for legal reference, analysis, and news, hosting an array of comprehensive comparative legal guides and research tools that cover law in more than 150 jurisdictions across 50 practice areas.
ICLG.com also provides daily legal news and event directories. At the heart of ICLG.com is an international network of legal experts, whose knowledge and experience are highly valued by legal and business professionals around the world.
CEE Legal Matters
Website: https://ceelegalmatters.com/
CEE Legal Matters is a print and online publication for and about lawyers interested and working in Europe's emerging legal markets. CEE Legal Matters features news, interviews, analysis, opinion, and more. We also host conferences and round-tables and produce special reports on fees, salaries, and other subjects of interest to lawyers in the region. Our mission is, simply, to be the go-to source of information about lawyers and legal markets in Central and Eastern Europe.
The Global IP Matrix
Website: https://www.gipmatrix.com/
The Global IP Matrix is the only print and digital IP industry-specific publication authored by legal professionals in the intellectual property sector. Our content is 100% contributed by IP industry legal professionals for professionals in the IP field.
Industry thought leaders provide comprehensive, detailed analysis reports on innovation, IP trends, new legislation, and IP strategy, amongst other topics in the IP spectrum internationally.
We have an unbiased approach, and we welcome thought leaders at all levels to share their knowledge and experience through sharing thought-provoking content.
For more info contact us at - [email protected] or call +44 (0)203 813 045
Women's IP World
Website: https://www.womensipworld.com/
The Women's IP World Annual was launched in 2019 to highlight and celebrate the work and achievements of women working in IP, IP Law & innovation globally. Women play significant roles in IP & Innovation that should be recognised and discussed at the highest level.
We endeavour to give women from all over the world (that work in IP Law and innovation) a voice and a platform to showcase their expertise and experiences of working in the industry and receive recognition for their outstanding work and achievements with other like-minded professionals working in these fields.
Our publication has received much attention from international IP organisations like INTA and AIPPI, who have contributed the opening letters to our last two annual editions. Our yearly publication has attracted a cocktail of awe-inspiring women from all over the world who are happy to share their profiles and experience working in the industry with our global audience.
The Women's IP World annual publication is produced only once per year. It is distributed monthly for one year at IP and innovation conferences and exhibitions all over the world. Our magazine is published in a few different formats, including print, digital and now in audio format via iTunes, PodOmatic, Spotify, Audible and Amazon Music for a more unintrusive listening experience.
Women's IP World 2022 presentation - https://www.youtube.com/watch?v=6SgpYU2uWto
Gene Therapy Net
Website: www.genetherapynet.com
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, hosting private dinners, to showcasing your brand and making valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
To discuss your objectives and partnership opportunities please contact [email protected].
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected].
GLOBAL IP STRATEGY HUB ADVISORY BOARD
Lorenz Kallenbach
Lorenz Kallenbach is a senior corporate patent counsel in the healthcare division of Merck KGaA. He is responsible for defining and executing the IP strategy for innovator projects. Including the assessment of the IP landscape, coordination of worldwide patent litigation, and portfolio development.
Before joining Merck, Lorenz worked in private practice. He is qualified as a German and European patent attorney.
Lorenz studied biochemistry and received a Ph.D. in the field of epigenetics.
Stephan Kutik
Nicolas Pourbaix
Christof Bull
Alexandra Moulson
Alex is an experienced leader and strategist with a broad background in marketing, product development, business development, portfolio management, and launch.
She has over 18 years of experience in pharmaceuticals, 8 years originators, 8 years biosimilars, and 2 years generics. Alex is British, with Biochemistry and MBA degrees.
Working backward, following her MBA, Alex was at McKinsey (reaching Associate Principal), at Morphosys was the Director for Business Development and at Sandoz brought a rituximab biosimilar to market and later led the Strategy Department for Sandoz. She is currently the Chief Development Officer for Polpharma Biologics.
Mike Cottler
Dr. Leslie Fischer
Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.
Ewan Nettleton
JOIN US IN BRUSSELS THIS YEAR
Venue
Le Louise Hotel Brussels, Avenue de la Toison d’Or, 40, B-1050 Brussels
This year's summit will be taking place at Le Louise Hotel Brussels
Click here to claim a discounted room rate: EUR220 per night inc VAT and service
City tax excluded (EUR 4.24 per night per bedroom)
Discounted rate availble until 2nd June 2023
BOOK YOUR PLACE TODAY
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
For more information on key dates, sponsors, webinars, virtual and in-person roundtables and other ways to get involved in the Global IP Series, download the 2023/2024 Marketing Solutions brochure below.
If you have any questions, please get in touch and our Marketing team will get back to you.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.